Insecticides (India) · NSE: INSECTICID · BSE: 532851

Q4 FY23 results · Jan–Mar 2023

Insecticides (India) reported revenue from operations of ₹301.90 crore (up 8.6% from Q4 FY22) and net loss of ₹29.30 crore for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations301.90277.98+8.6%356.53−15.3%
Other income0.412.09−80.2%0.37+10.2%
Total income302.31280.07+7.9%356.91−15.3%
Profit before share of associates & JVs and tax(38.98)28.10Turned loss12.36Turned loss
Share of profit/(loss) of associates & JVs(0.34)(0.06)0.09
Net profit for the period(29.30)22.33Turned loss9.37Turned loss
EPS, basic (₹)(9.90)11.32not comparable3.16Turned loss
Net margin (%)-9.78.02.6

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations301.90277.98+8.6%356.53−15.3%
Other income0.412.09−80.2%0.37+10.2%
Total income302.31280.07+7.9%356.91−15.3%
Profit before tax(39.03)28.10Turned loss12.42Turned loss
Net profit for the period(29.01)22.39Turned loss9.33Turned loss
EPS, basic (₹)(9.80)11.35not comparable3.15Turned loss
Net margin (%)-9.68.12.6
Consolidated
Filed with BSE
30 May 2023, 16:26 IST
Board meeting
30 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
30 May 2023, 16:26 IST
Board meeting
30 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE